Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy

Surgery for Obesity and Related Diseases

Volumn 9, Issue 4, 2013, Pages 498-502

  Abbatini, Francesca ^a   Capoccia, Danila ^a   Casella, Giovanni ^a   Soricelli, Emanuele ^a   Leonetti, Frida ^a   Basso, Nicola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bariatric; Metabolic surgery; Obesity; Sleeve gastrectomy; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; LAPAROSCOPIC SURGERY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REMISSION; SLEEVE GASTRECTOMY; WEIGHT GAIN; WEIGHT REDUCTION;

BARIATRIC; METABOLIC SURGERY; OBESITY; SLEEVE GASTRECTOMY; TYPE 2 DIABETES;

CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84881160338     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2012.09.003     Document Type: Article

References (37)

1. P. Hossain, B. Kawar, and M. El Nahas Obesity and diabetes in the developing world - a growing challenge N Engl J Med 356 2007 213 215
2. International Diabetes Federation Diabetes Atlas 3rd ed 2006 International Diabetes Federation Brussels
3. K. Yamaoka, and T. Tango Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials Diabetes Care 28 2005 2780 2786
4. J. Lindström, P. Ilanne-Parikka, and M. Peltonen Finnish Diabetes Prevention Study Lancet 368 2006 1673 1679
5. G. Li, P. Zhang, and J. Wang The long term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study Lancet 371 2008 1783 1789
6. D.M. Nathan, J.B. Buse, and M.B. Davidson Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 29 2006 1963 1972
7. R.C. Turner, C.A. Cull, V. Frighi, and R.R. Holman Glycaemic control with diet, sulfonylurea, metformin or insulin in patient with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS) Group JAMA 281 1999 2005 2012
8. A.B. Goldfine Assessing the cardiovascular safety of diabetes therapies N Engl J Med 359 2008 1092 1095
9. S. Havas The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom Arch Intern Med 169 2009 150 154
10. 2 J Gastrointest Surg 12 2008 945 952
11. H. Buchwald, Y. Avidor, and E. Braunwald Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
12. CD Sjöström, L Lissner, H Wedel, and L Sjöström Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study Obes Res 7 1999 477 484
13. L. Sjöström, K. Narbro, and C.D. Sjöström Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 2007 741 752
14. T.D. Adams, R.E. Gress, and S.C. Smith Long term mortality after gastric bypass surgery N Engl J Med 357 2007 753 761
15. J.B. Buse, S. Caprio, and W.T. Cefalu How do we define cure of diabetes? Diabetes Care 32 2009 2133 2135
16. F. Abbatini, M. Rizzello, and G. Casella Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes Surg Endosc 24 2010 1005 1010
17. M. Rizzello, F. Abbatini, and G. Casella Early postoperative insulin-resistance changes after sleeve gastrectomy Obes Surg 20 2010 50 522
18. N. Basso, D. Capoccia, and M. Rizzello First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis Surg Endosc 25 2011 3540 3550
19. A.E. Pontiroli, F. Folli, and M. Paganelli Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study Diabetes Care 28 2005 2703 2709
20. G. Mingrone, S. Panunzi, and A. De Gaetano Bariatric surgery versus conventional medical therapy for type 2 diabetes N Engl J Med 366 2012 1577 1585
21. P.R. Schauer, S.R. Kashyap, and K. Wolski Bariatric surgery versus intensive medical therapy in obese patients with diabetes N Engl J Med 366 2012 1567 1576
22. F. Leonetti, D. Capoccia, and F. Coccia Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment Arch Surg 147 2012 694 700
23. G. Casella, F. Abbatini, B. Calì, D. Capoccia, F. Leonetti, and N. Basso Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy Surg Obes Relat Dis 7 2011 697 702
24. N. Basso, G. Casella, and M. Rizzello Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases Surg Endosc 25 2011 444 449
25. Gagner M., Deitel M., Kalberer T.L., Erickson A.L., Crosby R.D. The second international consensus summit for sleeve gastrectomy, March 19-21, 2009. Surg Obes Relat Dis 2009;5:476-485.
26. M. DiGiorgi, D.J. Rosen, and J.J. Choi Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up Surg Obes Relat Dis 6 2010 249 253
27. C.D. Sjöström, T. Lystig, and A.K. Lindroos Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-years experiences from the SOS study Int J Obes (Lond) 35 2011 1413 1420
28. T.T. Søvik, E.T. Aasheim, and O. Taha Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial Ann Intern Med 155 2011 281 289
29. J.A. Batsis, M.G. Sarr, M.L. Collazo-Clavell, R.J. Thomas, A. Romero-Corral, V.K. Somers, and F. Lopez-Jimenez Cardiovascular risk after bariatric surgery for obesity Am J Cardiol 102 2008 930 937
30. N. de Fine Olivarius, V. Siersma, G.J. Almind, and N.V. Nielsen Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study BMC Public Health 11 2011 80
31. T. Rosenberg, and F. Klie Current trends in newly registered blindness in Denmark Acta Ophthalmol Scand 74 1996 395 398
32. M.A. Bamashmus, B. Matlhaga, and G.N. Dutton Causes of blindness and visual impairment in the West of Scotland Eye (Lond) 18 2004 257 261
33. P. Jeppesen, and T. Bek The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark Acta Ophthalmol Scand 82 2004 526 530
34. S. Prasad, G.G. Kamath, K. Jones, L.G. Clearkin, and R.P. Phillips Prevalence of blindness and visual impairment in a population of people with diabetes Eye (Lond) 15 2001 640 643
35. D.S. Fong, M. Sharza, W. Chen, J.F. Paschal, R.G. Ariyasu, and P.P. Lee Vision loss among diabetics in a group model Health Maintenance Organization (HMO) Am J Ophthalmol 133 2002 236 241
36. R. Klein, B.E. Klein, and S.E. Moss Visual impairment in diabetes Ophthalmology 91 1984 1 9
37. The ACCORD Study Group, ACCORD Eye Study Group, and EY Chew Effects of medical therapies on retinopathy progression in type 2 diabetes N Engl J Med 363 2010 233 244